Trial intelligence / Profile preview

Antidepressant Treatment Strategies for Korean MDD Patients

NCT00926835Phase 4Terminated

Start
May 2009
Primary completion
May 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of paroxetine, escitalopram, venlafaxine in major depressive disorder (MDD). Started May 2009; status: terminated.

02

Drugs

paroxetineescitalopramvenlafaxine
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on NCT00926835.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00926835.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call